Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials

Abstract excerpt

Recently, a number of phage therapy phase I and II safety trials have been concluded, showing no notable safety concerns associated with the use of phage. Though hurdles for efficient treatment remain, these trials hold promise for future phase III clinical trials. Interestingly, most phage formulations used in these clinical trials are straightforward phage suspensions, and not much research has focused on the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bacteriophages and microbial interactions
• Share to Monoclonal and Polyclonal Antibodies Research
• Share to Protein purification and stability